Ładuje się......
Antiviral peptide nanocomplexes as a potential antiviral therapeutic modality for HIV/HCV co-infection
It is estimated that 4 to 5 million people are currently co-infected with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). HIV/HCV co-infection is associated with unique health risks including increased hepatotoxicity of antiretrovirals, accelerated progression of HCV and liver diseas...
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3602242/ https://ncbi.nlm.nih.gov/pubmed/23403120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2013.01.026 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|